Serum lipids and endometrial cancer risk: Results from the HUNT‐II study

Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein choleste...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 124; no. 12; pp. 2938 - 2941
Main Authors Lindemann, Kristina, Vatten, Lars J., Ellstrøm‐Engh, Marie, Eskild, Anne
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.06.2009
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC
AbstractList Obesity is a major risk factor for endometrial cancer. Still, the association of obesity-related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein (non-HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow-up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age-adjusted hazard ratio was 2.34 (95% CI: 1.04-5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79-4.05). For total serum cholesterol, low-density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk.
Abstract Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC
Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein levels, is unclear. We prospectively examined the association of serum levels of triglycerides, total cholesterol, low‐density lipoprotein cholesterol, non–high‐density lipoprotein (non‐HDL), and HDL cholesterol with endometrial cancer risk among 31,473 women. During 9 years of follow‐up, 100 cases of endometrial cancer were identified by linkage to the Cancer Registry of Norway. There was a positive association of serum triglyceride levels with endometrial cancer risk. Comparing the highest to the lowest quartile of triglycerides, the age‐adjusted hazard ratio was 2.34 (95% CI: 1.04–5.28), and further adjustment for body mass index attenuated the association (hazard ratio 1.79, 95% CI: 0.79–4.05). For total serum cholesterol, low‐density lipoprotein cholesterol and HDL cholesterol there were no associations with endometrial cancer risk, either without or after adjustment for body mass index. Serum triglyceride levels were positively associated with the risk of endometrial cancer, and some of the association seems to be attributable to obesity. Apart from higher estrogen levels produced in adipose tissue, mechanisms more specifically related to triglycerides may also be involved in endometrial cancer. Further prospective studies on this subject are needed to better understand the association of blood lipids with endometrial cancer risk. © 2009 UICC
Author Eskild, Anne
Ellstrøm‐Engh, Marie
Lindemann, Kristina
Vatten, Lars J.
Author_xml – sequence: 1
  givenname: Kristina
  surname: Lindemann
  fullname: Lindemann, Kristina
  email: kristina.lindemann@ahus.no
– sequence: 2
  givenname: Lars J.
  surname: Vatten
  fullname: Vatten, Lars J.
– sequence: 3
  givenname: Marie
  surname: Ellstrøm‐Engh
  fullname: Ellstrøm‐Engh, Marie
– sequence: 4
  givenname: Anne
  surname: Eskild
  fullname: Eskild, Anne
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21370929$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19267407$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/147434$$DView record from Swedish Publication Index
BookMark eNqF0c1OFTEUB_DGYOSCLnwB040kLAb6Ne2MO3ODcgnRRGHddNozWJwv22nI3fkIPKNPQmFucGVcNTn95ZyT8z9Ae8M4AEJvKTmhhLBTf2tPmGBV-QKtKKlVQRgt99Aq_5FCUS730UGMt4RQWhLxCu3TmkkliFqhi-8QUo87P3kXsRkchsGNPczBmw5bM1gIOPj48wP-BjF1c8RtGHs8_wB8fv3l6s_v-80Gxzm57Wv0sjVdhDe79xBdfzq7Wp8Xl18_b9YfLwtbMl4WktZglagYM6KUjtuqLKXkjWulVVVjGuYcCCFaQ5VsakZaKptK1jXljkvZ8ENULH3jHUyp0VPwvQlbPRqvb9Kkc-km6QiaCiW4yP5o8VMYfyWIs-59tNB1ZoAxRS3zhSqu6v9CRiSnqiIZHi_QhjHGAO3zDpTox0R0TkQ_JZLtu13T1PTg_spdBBm83wETrenakG_u47NjlCtSs8ftThd35zvY_nui3lysl9EPOGqjEA
CODEN IJCNAW
CitedBy_id crossref_primary_10_1016_j_ygyno_2024_02_017
crossref_primary_10_1002_ijc_33206
crossref_primary_10_1017_S1368980011001066
crossref_primary_10_1111_eci_12185
crossref_primary_10_1007_s12020_013_9973_3
crossref_primary_10_1155_2015_593658
crossref_primary_10_1158_1055_9965_EPI_10_0832
crossref_primary_10_1002_cncr_25455
crossref_primary_10_4178_epih_e2023049
crossref_primary_10_1186_s12885_023_11053_4
crossref_primary_10_18632_aging_103247
crossref_primary_10_1186_s12885_024_12434_z
crossref_primary_10_3389_fonc_2023_1052760
crossref_primary_10_1093_jjco_hyt125
crossref_primary_10_1155_2013_823849
crossref_primary_10_1097_IGC_0000000000000819
crossref_primary_10_1186_s41231_022_00129_1
crossref_primary_10_1080_01635581_2023_2294521
crossref_primary_10_1515_HMBCI_2010_027
crossref_primary_10_1186_s12958_022_01006_0
crossref_primary_10_3390_cancers14194912
crossref_primary_10_1158_1055_9965_EPI_11_0715
crossref_primary_10_1186_s12916_022_02322_3
crossref_primary_10_1530_ERC_17_0449
crossref_primary_10_1093_annonc_mdq464
crossref_primary_10_4236_ijcm_2015_612129
crossref_primary_10_1186_s12967_022_03851_4
crossref_primary_10_1371_journal_pone_0104630
crossref_primary_10_1007_s13277_016_4799_2
crossref_primary_10_1093_hropen_hoae033
crossref_primary_10_3109_09513590_2015_1058355
crossref_primary_10_1016_j_biopha_2023_114526
crossref_primary_10_1002_cam4_5463
crossref_primary_10_1186_s12916_022_02246_y
crossref_primary_10_2147_IJGM_S352934
crossref_primary_10_3390_cancers12051292
crossref_primary_10_1093_annonc_mdv142
crossref_primary_10_1016_j_biochi_2014_03_010
crossref_primary_10_56766_ntms_1297303
crossref_primary_10_7759_cureus_62099
crossref_primary_10_1016_j_ygyno_2009_12_029
crossref_primary_10_1080_01443615_2020_1819210
crossref_primary_10_1186_1471_2288_12_21
crossref_primary_10_1007_s10552_017_0991_y
crossref_primary_10_4236_jdm_2022_122011
Cites_doi 10.1016/S0022-2275(20)42625-2
10.1101/gad.8.10.1224
10.1016/0021-9681(80)90026-0
10.1186/1476-4598-5-13
10.1159/000063081
10.1677/ERC-07-0132
10.1210/jc.80.7.2057
10.1093/clinchem/18.6.499
10.1158/1078-0432.CCR-05-1833
10.1016/S0002-9343(99)80058-8
10.1016/S0026-0495(97)90159-1
10.1056/NEJM199908053410604
10.1126/science.294.5548.1866
10.33549/physiolres.930848
10.1007/s00059-005-2708-3
10.1056/NEJM198711123172001
10.1001/jama.1981.03310280023021
10.1046/j.1365-2796.2002.01025.x
10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T
10.1007/BF00052142
10.1155/2008/102737
10.1210/jc.2003-031716
10.1038/sj.bjc.6604313
10.1046/j.1440-1711.2000.00921.x
10.1038/sj.ijo.0802806
ContentType Journal Article
Copyright Copyright © 2009 UICC
2009 INIST-CNRS
Copyright 2008 UICC.
Copyright_xml – notice: Copyright © 2009 UICC
– notice: 2009 INIST-CNRS
– notice: Copyright 2008 UICC.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U1
7U2
C1K
7X8
ADTPV
AOWAS
F1U
DOI 10.1002/ijc.24285
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Risk Abstracts
Safety Science and Risk
Environmental Sciences and Pollution Management
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Risk Abstracts
Safety Science and Risk
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE

MEDLINE - Academic
Risk Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 2941
ExternalDocumentID oai_gup_ub_gu_se_147434
10_1002_ijc_24285
19267407
21370929
IJC24285
Genre article
Randomized Controlled Trial
Multicenter Study
Journal Article
GeographicLocations Norway
GeographicLocations_xml – name: Norway
GroupedDBID ---
-~X
.3N
.55
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZZTAW
~IA
~WT
.GJ
3O-
8WZ
A6W
AAJUZ
AAPBV
AAUGY
AAVGM
ABCVL
ABEFU
ABEML
ABHUG
ABWRO
ACBWZ
ACSCC
ACSMX
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
AHEFC
AI.
ASPBG
AVWKF
AZFZN
BDRZF
EMOBN
FEDTE
GLUZI
IQODW
M6P
PALCI
SAMSI
VH1
Y6R
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U1
7U2
C1K
7X8
ADTPV
AOWAS
F1U
HVGLF
ID FETCH-LOGICAL-c5235-619ec74822a456d3c855663bdf6c78bab2dde444fa176b920f16b869913d366b3
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Sat Aug 24 00:42:59 EDT 2024
Sat Aug 17 04:04:53 EDT 2024
Fri Aug 16 08:51:43 EDT 2024
Fri Aug 23 01:23:02 EDT 2024
Sat Sep 28 07:57:02 EDT 2024
Sun Oct 22 16:07:28 EDT 2023
Sat Aug 24 00:55:12 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Obesity
Endometrium cancer
Nutrition disorder
Lipids
Malignant tumor
Epidemiology
Blood
blood lipids
Female genital diseases
Cancerology
Risk factor
Uterine diseases
endometrial cancer
Serum
Nutritional status
Cancer
Language English
License CC BY 4.0
Copyright 2008 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5235-619ec74822a456d3c855663bdf6c78bab2dde444fa176b920f16b869913d366b3
Notes Fax: ++47‐67‐92‐8845.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-News-2
ObjectType-Feature-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.24285
PMID 19267407
PQID 20631780
PQPubID 23462
PageCount 4
ParticipantIDs swepub_primary_oai_gup_ub_gu_se_147434
proquest_miscellaneous_67138379
proquest_miscellaneous_20631780
crossref_primary_10_1002_ijc_24285
pubmed_primary_19267407
pascalfrancis_primary_21370929
wiley_primary_10_1002_ijc_24285_IJC24285
PublicationCentury 2000
PublicationDate 15 June 2009
PublicationDateYYYYMMDD 2009-06-15
PublicationDate_xml – month: 06
  year: 2009
  text: 15 June 2009
  day: 15
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2009
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley-Blackwell
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley-Blackwell
References 1990; 31
1991; 2
2002; 252
1981; 245
2006; 12
2006; 55
2004; 28
1997; 46
2004; 89
2002; 11
1995; 98
1999; 341
2006; 5
2008; 98
1993; 149
2008; 2008
2007; 14
1982; 68
1994; 8
2001; 294
1995; 80
2000; 78
2002; 46
1980; 33
1997; 57
1987; 317
2001; 19
2005; 30
1994; 3
1972; 18
e_1_2_5_26_2
e_1_2_5_27_2
e_1_2_5_24_2
e_1_2_5_25_2
e_1_2_5_22_2
e_1_2_5_23_2
Bergstrom A (e_1_2_5_2_2) 2001; 19
e_1_2_5_21_2
Shumak SL (e_1_2_5_16_2) 1993; 149
e_1_2_5_28_2
e_1_2_5_29_2
Swanson CA (e_1_2_5_12_2) 1994; 3
e_1_2_5_14_2
Wallace RB (e_1_2_5_19_2) 1982; 68
e_1_2_5_13_2
Kaaks R (e_1_2_5_4_2) 2002; 11
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_31_2
e_1_2_5_11_2
e_1_2_5_3_2
e_1_2_5_18_2
Goodman MT (e_1_2_5_20_2) 1997; 57
e_1_2_5_17_2
Housa D (e_1_2_5_9_2) 2006; 55
e_1_2_5_30_2
References_xml – volume: 14
  start-page: 755
  year: 2007
  end-page: 67
  article-title: Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
  publication-title: Endocr Relat Cancer
– volume: 80
  start-page: 2057
  year: 1995
  end-page: 62
  article-title: Effects of diet and metformin administration on sex hormone‐binding globulin, androgens, and insulin in hirsute and obese women
  publication-title: J Clin Endocrinol Metab
– volume: 57
  start-page: 5077
  year: 1997
  end-page: 85
  article-title: Diet, body size, physical activity, and the risk of endometrial cancer
  publication-title: Cancer Res
– volume: 3
  start-page: 575
  year: 1994
  end-page: 81
  article-title: Endometrial cancer risk in relation to serum lipids and lipoprotein levels
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 31
  start-page: 1149
  year: 1990
  end-page: 72
  article-title: Dietary influences on serum lipids and lipoproteins
  publication-title: J Lipid Res
– volume: 252
  start-page: 164
  year: 2002
  end-page: 72
  article-title: Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord‐Trondelag. Health Study (HUNT, 1995–97), Norway
  publication-title: J Intern Med
– volume: 78
  start-page: 436
  year: 2000
  end-page: 41
  article-title: Peroxisome proliferator‐activated receptors in tumorigenesis: targets of tumour promotion and treatment
  publication-title: Immunol Cell Biol
– volume: 12
  start-page: 4200
  year: 2006
  end-page: 8
  article-title: Peroxisome proliferator‐activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma
  publication-title: Clin Cancer Res
– volume: 149
  start-page: 843
  year: 1993
  end-page: 4
  article-title: Intraindividual variation in lipid and lipoprotein levels
  publication-title: CMAJ
– volume: 89
  start-page: 1160
  year: 2004
  end-page: 3
  article-title: Circulating adiponectin and endometrial cancer risk
  publication-title: J Clin Endocrinol Metab
– volume: 11
  start-page: 1531
  year: 2002
  end-page: 43
  article-title: Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 8
  start-page: 1224
  year: 1994
  end-page: 34
  article-title: mPPAR gamma 2: tissue‐specific regulator of an adipocyte enhancer
  publication-title: Genes Dev
– volume: 19
  start-page: 421
  year: 2001
  end-page: 30
  article-title: Overweight as an avoidable cause of cancer in Europe
  publication-title: Int J Cancer
– volume: 2008
  start-page: 102737
  year: 2008
  article-title: The role of PPARs in cancer
  publication-title: PPAR Res
– volume: 55
  start-page: 233
  year: 2006
  end-page: 44
  article-title: Adipocytokines and cancer
  publication-title: Physiol Res
– volume: 28
  start-page: S75
  issue: Suppl 3
  year: 2004
  end-page: S80
  article-title: Hormones regulating lipid metabolism and plasma lipids in childhood obesity
  publication-title: Int J Obes Relat Metab Disord
– volume: 46
  start-page: 147
  year: 2002
  end-page: 51
  article-title: Leptin and body mass index in relation to endometrial cancer risk
  publication-title: Ann Nutr Metab
– volume: 294
  start-page: 1866
  year: 2001
  end-page: 70
  article-title: Nuclear receptors and lipid physiology: opening the X‐files
  publication-title: Science
– volume: 317
  start-page: 1237
  year: 1987
  end-page: 45
  article-title: Helsinki Heart Study: primary‐prevention trial with gemfibrozil in middle‐aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
  publication-title: N Engl J Med
– volume: 33
  start-page: 311
  year: 1980
  end-page: 32
  article-title: The relationship of serum cholesterol to the incidence of cancer in Evans County. Georgia
  publication-title: J Chronic Dis
– volume: 98
  start-page: 40S
  year: 1995
  end-page: 47S
  article-title: Endogenous sex hormones: impact on lipids, lipoproteins, and insulin
  publication-title: Am J Med
– volume: 5
  start-page: 13
  year: 2006
  article-title: In vitro and in vivo effects of the PPAR‐alpha agonists fenofibrate and retinoic acid in endometrial cancer
  publication-title: Mol Cancer
– volume: 98
  start-page: 1582
  year: 2008
  end-page: 5
  article-title: Body mass, diabetes and smoking, and endometrial cancer risk: a follow‐up study
  publication-title: Br J Cancer
– volume: 2
  start-page: 253
  year: 1991
  end-page: 61
  article-title: Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies
  publication-title: Cancer Causes Control
– volume: 30
  start-page: 368
  year: 2005
  end-page: 74
  article-title: Lipids and lipoproteins in women
  publication-title: Herz
– volume: 46
  start-page: 5
  year: 1997
  end-page: 9
  article-title: Determinants of sex hormone‐binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio‐Menopause‐Health Group
  publication-title: Metabolism
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  article-title: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin Chem
– volume: 245
  start-page: 247
  year: 1981
  end-page: 52
  article-title: Cancer incidence by levels of cholesterol
  publication-title: JAMA
– volume: 68
  start-page: 915
  year: 1982
  end-page: 8
  article-title: Cancer incidence in humans: relationship to plasma lipids and relative weight
  publication-title: J Natl Cancer Inst
– volume: 341
  start-page: 410
  year: 1999
  end-page: 8
  article-title: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high‐density lipoprotein cholesterol. Veterans Affairs High‐Density Lipoprotein Cholesterol Intervention Trial Study Group
  publication-title: N Engl J Med
– ident: e_1_2_5_10_2
  doi: 10.1016/S0022-2275(20)42625-2
– volume: 57
  start-page: 5077
  year: 1997
  ident: e_1_2_5_20_2
  article-title: Diet, body size, physical activity, and the risk of endometrial cancer
  publication-title: Cancer Res
  contributor:
    fullname: Goodman MT
– ident: e_1_2_5_25_2
  doi: 10.1101/gad.8.10.1224
– volume: 3
  start-page: 575
  year: 1994
  ident: e_1_2_5_12_2
  article-title: Endometrial cancer risk in relation to serum lipids and lipoprotein levels
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Swanson CA
– ident: e_1_2_5_18_2
  doi: 10.1016/0021-9681(80)90026-0
– ident: e_1_2_5_30_2
  doi: 10.1186/1476-4598-5-13
– ident: e_1_2_5_7_2
  doi: 10.1159/000063081
– ident: e_1_2_5_11_2
  doi: 10.1677/ERC-07-0132
– ident: e_1_2_5_5_2
  doi: 10.1210/jc.80.7.2057
– ident: e_1_2_5_15_2
  doi: 10.1093/clinchem/18.6.499
– volume: 68
  start-page: 915
  year: 1982
  ident: e_1_2_5_19_2
  article-title: Cancer incidence in humans: relationship to plasma lipids and relative weight
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Wallace RB
– ident: e_1_2_5_31_2
  doi: 10.1158/1078-0432.CCR-05-1833
– ident: e_1_2_5_22_2
  doi: 10.1016/S0002-9343(99)80058-8
– ident: e_1_2_5_6_2
  doi: 10.1016/S0026-0495(97)90159-1
– ident: e_1_2_5_29_2
  doi: 10.1056/NEJM199908053410604
– volume: 11
  start-page: 1531
  year: 2002
  ident: e_1_2_5_4_2
  article-title: Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review
  publication-title: Cancer Epidemiol Biomarkers Prev
  contributor:
    fullname: Kaaks R
– ident: e_1_2_5_24_2
  doi: 10.1126/science.294.5548.1866
– volume: 55
  start-page: 233
  year: 2006
  ident: e_1_2_5_9_2
  article-title: Adipocytokines and cancer
  publication-title: Physiol Res
  doi: 10.33549/physiolres.930848
  contributor:
    fullname: Housa D
– ident: e_1_2_5_21_2
  doi: 10.1007/s00059-005-2708-3
– ident: e_1_2_5_28_2
  doi: 10.1056/NEJM198711123172001
– ident: e_1_2_5_17_2
  doi: 10.1001/jama.1981.03310280023021
– ident: e_1_2_5_14_2
  doi: 10.1046/j.1365-2796.2002.01025.x
– volume: 19
  start-page: 421
  year: 2001
  ident: e_1_2_5_2_2
  article-title: Overweight as an avoidable cause of cancer in Europe
  publication-title: Int J Cancer
  doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T
  contributor:
    fullname: Bergstrom A
– ident: e_1_2_5_13_2
  doi: 10.1007/BF00052142
– volume: 149
  start-page: 843
  year: 1993
  ident: e_1_2_5_16_2
  article-title: Intraindividual variation in lipid and lipoprotein levels
  publication-title: CMAJ
  contributor:
    fullname: Shumak SL
– ident: e_1_2_5_27_2
  doi: 10.1155/2008/102737
– ident: e_1_2_5_8_2
  doi: 10.1210/jc.2003-031716
– ident: e_1_2_5_3_2
  doi: 10.1038/sj.bjc.6604313
– ident: e_1_2_5_26_2
  doi: 10.1046/j.1440-1711.2000.00921.x
– ident: e_1_2_5_23_2
  doi: 10.1038/sj.ijo.0802806
SSID ssj0011504
Score 2.239683
Snippet Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and lipoprotein...
Obesity is a major risk factor for endometrial cancer. Still, the association of obesity-related metabolic factors, such as serum lipids and lipoprotein...
Abstract Obesity is a major risk factor for endometrial cancer. Still, the association of obesity‐related metabolic factors, such as serum lipids and...
SourceID swepub
proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2938
SubjectTerms Biological and medical sciences
blood
blood lipids
Cholesterol
Cholesterol - blood
Cholesterol, HDL - blood
Cholesterol, LDL - blood
endometrial cancer
Endometrial Neoplasms
Endometrial Neoplasms - blood
Endometrial Neoplasms - epidemiology
epidemiology
Female
Female genital diseases
Follow-Up Studies
Gynecology. Andrology. Obstetrics
HDL
Humans
LDL
Lipids
Lipids - blood
Medical sciences
Middle Aged
Norway
Norway - epidemiology
obesity
Obstetrics, Gynecology and Reproductive Medicine
Prospective Studies
Questionnaires
Reproduktionsmedicin och gynekologi
Risk Assessment
Risk Factors
Surveys and Questionnaires
Triglycerides
Triglycerides - blood
Tumors
Title Serum lipids and endometrial cancer risk: Results from the HUNT‐II study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.24285
https://www.ncbi.nlm.nih.gov/pubmed/19267407
https://search.proquest.com/docview/20631780
https://search.proquest.com/docview/67138379
https://gup.ub.gu.se/publication/147434
Volume 124
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6UPogg1nqN2jqIiC_ZJplLJvokxbK70D6ULvRBGOaWsrbNLs3mxSd_gr_RX-KZZJOyYkF8C8mZkJlzme9k5nwD8A4jnDVc2tj4tIyZZzLWPDFxlnuqHTW0EKE4-fhEjGdses7Pt-BTXwvT8UMMP9yCZ7TxOji4NvXBLWno_Jsd4fwiQ4F5INILgOh0oI4KQGfNwJzEmIiJnlUoyQ6Glhtz0YOlrnFYyu48i78BzoFNdBPItjPR0Q587fvQbUC5HDUrM7Lf_6B3_M9OPoKHa4RKPncmtQtbvnoM947Xa_BPYIrhpbkmV_Pl3NVEV474yi2ufXv-B7HBim5I2LH-kZz6urla1STUsBBEmmQ8Ozn79ePnZEJaWtunMDv6cnY4jtcnMsQWE1aOeWbhbc4QVGgEXo5ayREOUuNKYXNptMkwWjLGSp3mwhRZUqbCSIEYlDoqhKHPYLtaVP4FEOls4i0vecFK5rjU3gnDObakzlCmI3jb60YtO-IN1VEsZwpHRbWjEsH-htYGySyleYLIL4I3vRoV-k1YDNGVXzS1yhCbpblM7pYQaDaYvuM7nnf6v_2OIhM5ZsIRvO8MYngSyLovmqXCWxeNqj1mVgjRWAQfWi3f3RM1mR62Fy__XfQV3O_WtkSc8tewvbpp_B5CpJXZb33hN4dADQo
link.rule.ids 230,315,786,790,891,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFH4qRQIkxE4xSztCCHFxansW24gLKlRJaHKoEqkXNJrNVWjrRHV84cRP4DfyS3hjJ66CqIS4WeMZy2_eMt-b5RuANxjhjOaZCbWLi5A5loWKRzpMUkeVpZrmwh9OHo1Ff8qGJ_xkCz6sz8K0_BDdhJv3jCZeewf3E9L7V6yhs2-mhwNMxm_ATXR37t3y03FHHuWhzoqDOQoxFRNrXqEo2e-aboxGdxeqwo4p2hst_gY5Oz7RTSjbjEWH9-HrWop2C8pZr17qnvn-B8Hj_4r5AO6tQCr52FrVQ9hy5SO4NVotwz-GIUaY-oKczxYzWxFVWuJKO79wzRUgxHhDuiR-0_p7cuyq-nxZEX-MhSDYJP3pePLrx8_BgDTMtk9gevh5ctAPV5cyhAZzVo6pZu5MyhBXKMRelpqMIyKk2hbCpJlWOsGAyRgrVJwKnSdREQudCYSh1FIhNH0K2-W8dM-AZNZEzvCC56xglmfKWaE5x5bUaspUAK_XypGLlntDtizLicRekU2vBLC7obauZhLTNELwF8DeWo8SXcevh6jSzetKJgjP4jSLrq8h0G4wg8dv7LQGcPUfeSJSTIYDeNtaRPfG83Wf1guJRae1rBwmV4jSWADvGjVfL4kcDA-ah-f_XnUPbvcnoyN5NBh_eQF32qUuEcb8JWwvL2v3ChHTUu82jvEbUSURKg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3batRAGP6pFYog9VgbD-0gIt5km2QOSfRKWpfd1S5SutALYZhTymqbDc3mxisfwWf0SfyTbFJWLIh3IZkJmfkP832ZmW8AXmGGM5onxtcuzHzmWOIrHmg_ih1Vlmqainpz8vFUjGZscsbPNuBdtxem1Yfof7jVkdHk6zrAC5sdXIuGzr-aAY4vCb8Ft5mgUc28jk567aga6awkmAMfmZjoZIWC6KCvujYY3S1Uif2StQda_A1x9nKi60i2GYqG9-BL14h2Bcq3QbXUA_P9D33H_2zlfdheQVTyvvWpB7Dh8oewdbyahH8EE8wv1SW5mBdzWxKVW-Jyu7h0zQEgxNRudEXqJetvyYkrq4tlSepNLAShJhnNpqe_fvwcj0mja_sYZsMPp4cjf3Ukg2-QsXIkmqkzMUNUoRB5WWoSjniQapsJEyda6QjTJWMsU2EsdBoFWSh0IhCEUkuF0HQHNvNF7naBJNYEzvCMpyxjlifKWaE5x5rUasqUBy8728iiVd6QrcZyJLFXZNMrHuytWa0vGYU0DhD6ebDfmVFi4NSzISp3i6qUEYKzME6Cm0sIdBvk7_iOJ639r78jjUSMVNiD161D9E9qte7zqpB467ySpUNqhRiNefCmsfLNLZHjyWFz8fTfi-7D1uejofw0nn58BnfaeS7hh_w5bC6vKvcC4dJS7zVh8RsZSg_Z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+and+endometrial+cancer+risk%3A+Results+from+the+HUNT%E2%80%90II+study&rft.jtitle=International+journal+of+cancer&rft.au=Lindemann%2C+Kristina&rft.au=Vatten%2C+Lars+J.&rft.au=Ellstr%C3%B8m%E2%80%90Engh%2C+Marie&rft.au=Eskild%2C+Anne&rft.date=2009-06-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=124&rft.issue=12&rft.spage=2938&rft.epage=2941&rft_id=info:doi/10.1002%2Fijc.24285&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ijc_24285
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon